HomeAQB • NASDAQ
add
Aquabounty Technologies Inc
Previous close
$0.92
Year range
$0.60 - $2.95
Market cap
4.81M USD
Avg Volume
29.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -729.46K | -136.51% |
Net income | -14.14M | 83.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 955.50K | 148.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 501.30K | 117.61% |
Total assets | 10.34M | -69.63% |
Total liabilities | 12.23M | -32.86% |
Total equity | -1.89M | — |
Shares outstanding | 5.15M | — |
Price to book | -1.88 | — |
Return on assets | 10.57% | — |
Return on capital | 16.73% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -14.14M | 83.19% |
Cash from operations | -3.18M | -185.22% |
Cash from investing | 24.00K | -96.69% |
Cash from financing | 2.70M | 2,073.93% |
Net change in cash | -450.14K | -66.67% |
Free cash flow | -4.10M | -115.07% |
About
AquaBounty Technologies is a biotechnology and aquaculture company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of the company's AquAdvantage salmon has been approved in Canada and the United States. The company sold all of its operating farms and ceased fish production in 2024. Wikipedia
Founded
1991
Headquarters
Website
Employees
3
